Prof. Dr. med. Luc Biedermann is currently a chief physician at the Clinic for Gastroenterology and Hepatology, University Hospital Zurich, Switzerland. He has been a board-certified specialist in Gastroenterology and Hepatology since 2012, focusing on inflammatory bowel disease (IBD). He has been Head of IBD, USZ, since August 2017, and Head of the Eosinophilic Esophagitis (EoE) Outpatient Clinic of the USZ with Prof. Alex Straumann since 2016. Amongst his main clinical and research interests are epidemiology, natural history and course of IBD, clinical trials in IBD, intestinal microbiota in IBD, environmental factors in IBD, fecal transplantation and recurrent Clostridium difficile infection, celiac disease, and, of course, EoE.
Hans Herfarth is a clinical researcher with expertise is in inflammatory bowel diseases with the focus to improve diagnostic and therapeutic approaches in this field. He has extensive expertise in conducting investigator-initiated trials as well as coordinating data and specimen collections in large multicenter approaches. He was the PI of an investigator initiated study of methotrexate for ulcerative colitis – MERIT-UC that was funded through the NIH U01 mechanism. The results were published online in Gastroenterology in October 2018. His research is currently supported by grants from the Patient-Centered Outcomes Research Institute (PCORI) and industry in the context of investigator-initiated studies. Dr. Herfarth is the Co-director of the UNC Multidisciplinary IBD Center and in this role, he is involved in coordinating the clinical care of the patients as well as clinical IBD research at UNC.
